Is injection-site erythema on semaglutide dose-dependent or dose-rate dependent?

What I am working with: injection-site erythema · semaglutide.

I understand the observation; what I do not understand is the mechanism behind it.

I have read the two review articles that come up first and both assert this without a citation to a primary source.

So what is the mechanism, and how well established is it?

The short version: usually mild, usually resolving in days, and distinguishable from infection by systemic features and by trajectory.

Marking the edge of an area of redness with a pen and a time is the cheapest way to establish whether it is expanding, and it converts an impression into an observation.

Local reaction versus infection

The relevant detail is that repeated reactions in the same anatomical area suggest inadequate rotation. Lipohypertrophy presents as a firm painless thickening and alters absorption from that site.

Injection-site reactions are reported in the trial programmes for this class at low single-figure to low double-figure percentages depending on agent and formulation.

Fever or spreading redness is a clinical problem. Do not wait it out.

A firm nodule that persists for weeks may be lipohypertrophy rather than a reaction, and the management is rotation.

A delayed local reaction — erythema, induration and itch appearing hours later and settling over two to four days — is a local immune response and is the common benign pattern.

A reaction after every injection regardless of site, particularly with any systemic feature, is a different question and should be raised with a clinician rather than managed by rotation.

Repeated reactions in one area means rotation, not a different compound.

Photographing the site with a date is worth more than describing it later from memory.

Features that point towards infection rather than reaction: expanding redness beyond a few centimetres, increasing rather than decreasing pain after forty-eight hours, warmth, fluctuance, fever or malaise.

More usefully, bruising is a mechanical event from a small vessel and is unrelated to the compound; it is more likely with a blunted needle or a fast insertion.

Lipohypertrophy from repeated injection into the same site is documented in large observational studies of injection practice and alters absorption.

Improving after forty-eight hours is reassuring. Worsening is not.

Start by separating the immediate stinging on injection from a delayed reaction appearing hours later — they have different causes.

Immediate stinging is usually the injectate: cold solution, a preservative, or a hypotonic diluent. Room-temperature solution injected slowly removes most of it.

The caveat is that a spreading, worsening or febrile reaction is a clinical situation and needs seeing rather than describing.

Room-temperature solution, slow push, fresh needle. That removes most immediate stinging.

The relevant point is that repeated reactions at the same site suggest technique or rotation rather than a reaction to the compound.

Cellulitis after subcutaneous injection is uncommon but real, and it is the reason the trajectory matters more than the appearance at any single moment. Getting better is reassuring; getting worse is not.

Absence of infection cannot be established from a description on a forum, which is why the discriminating features matter more than reassurance.

Mark the edge with a pen and note the time. Expanding is the signal that matters.

edited 15 May 2026 by rota_site — reworded for clarity after a comment